Company Directory › Robotics › Complete Robots & Platforms › Ekso Bionics vs Elephant Robotics

Ekso Bionics vs Elephant Robotics

Ekso Bionics and Elephant Robotics are both complete robots & platforms companies. Their verified profiles differ on headquarters, country, industry focus, founding year and markets served. The table below sets out only those rows; everything else is on each company's own profile. Facts verified 6 November 2026.

Where they differ

Company Ekso Bionics Elephant Robotics
Headquarters San Rafael, California, United States Shenzhen, Guangdong, China
Country United States China
Industry Wearable robotics — medical exoskeletons for rehabilitation and personal mobility Complete robots — desktop & collaborative robot arms, companion robots, humanoids
Founded 2005 2016
Markets served Rehabilitation hospitals, outpatient clinics and home users in the United States and international markets Global — the company’s documentation names China, the UK, the US, Germany, France and Japan as core markets; third-party sources report myCobot sales in more than 50 countries

How Ekso Bionics and Elephant Robotics differ

Where the robot meets the body is the thread here, worn in one case, desk-based in the other. Ekso Bionics, headquartered in San Rafael, California and founded in 2005 as Berkeley ExoWorks out of a University of California, Berkeley laboratory, renamed Berkeley Bionics in 2007 and Ekso Bionics in 2011, makes powered exoskeletons for medical rehabilitation and personal mobility. It serves rehabilitation hospitals, outpatient clinics and home users in the United States and international markets. Its ownership changed recently: the business was acquired by Wandercraft in a deal announced on 1 October 2026 on undisclosed terms, after its previously Nasdaq-listed parent renamed itself ChronoScale Holdings in 2026 and divested it. Elephant Robotics, headquartered in Shenzhen, Guangdong, China and founded in 2016, makes small, affordable collaborative robots, known for the myCobot series of desktop six-axis arms, alongside companion robots and humanoids. Its documentation names China, the UK, the US, Germany, France and Japan as core markets, with third-party sources reporting myCobot sales in more than 50 countries. It discloses funding rounds from seed through Series A++ without amounts and no cumulative total. Neither discloses company size. Clinical and mobility buyers and desktop-arm buyers are reading different records.

Frequently asked questions

What is the main difference between Ekso Bionics and Elephant Robotics?

Ekso Bionics is based in San Rafael, California, United States and Elephant Robotics in Shenzhen, Guangdong, China; they also differ on country, industry focus, founding year, markets served. The table above sets out both companies' entries row by row.

Are Ekso Bionics and Elephant Robotics in the same country?

No. Ekso Bionics is based in San Rafael, California, United States and Elephant Robotics in Shenzhen, Guangdong, China.

Can one sourcing request reach both Ekso Bionics and Elephant Robotics?

Yes. Ekso Bionics can be reached through eksobionics.com and Elephant Robotics through elephantrobotics.com, or post one sourcing request and let both answer if they fit.

Does GlobleMatch rank Ekso Bionics above Elephant Robotics, or Elephant Robotics above Ekso Bionics?

Neither. There is no pay-to-rank and no paid placement in comparisons; order and content come from verified profile facts only.

Sourcing from complete robots & platforms companies?

Post your request once and receive answers from matching suppliers, including Ekso Bionics and Elephant Robotics. The choice comes down to geography and product range — the table above shows where each one stands. Posting is free for buyers.

Post a sourcing request

Run Ekso Bionics or Elephant Robotics? Claim your free profile to keep your facts current.

Full profiles, with every fact and its source: Ekso Bionics and Elephant Robotics. Profile facts last verified: Ekso Bionics on 6 November 2026, Elephant Robotics on 6 November 2026.